174 related articles for article (PubMed ID: 15731287)
1. Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis.
Barton A; Bowes J; Eyre S; Symmons D; Worthington J; Silman A
Ann Rheum Dis; 2005 Sep; 64(9):1311-5. PubMed ID: 15731287
[TBL] [Abstract][Full Text] [Related]
2. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
[TBL] [Abstract][Full Text] [Related]
5. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
Zavala-Cerna MG; Gonzalez-Montoya NG; Nava A; Gamez-Nava JI; Moran-Moguel MC; Rosales-Gomez RC; Gutierrez-Rubio SA; Sanchez-Corona J; Gonzalez-Lopez L; Davalos-Rodriguez IP; Salazar-Paramo M
Clin Dev Immunol; 2013; 2013():383681. PubMed ID: 24454473
[TBL] [Abstract][Full Text] [Related]
6. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population.
Barton A; Bowes J; Eyre S; Spreckley K; Hinks A; John S; Worthington J
Arthritis Rheum; 2004 Apr; 50(4):1117-21. PubMed ID: 15077293
[TBL] [Abstract][Full Text] [Related]
7. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
[TBL] [Abstract][Full Text] [Related]
8. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
[TBL] [Abstract][Full Text] [Related]
9. Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort.
Du Y; Liu X; Guo JP; Liu X; Li R; Zhao Y; Liu X; Li MH; Li ZG
Clin Exp Rheumatol; 2014; 32(3):377-82. PubMed ID: 24564960
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
11. PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients.
Abd-Allah SH; el-Shal AS; Shalaby SM; Pasha HF; Abou el-Saoud AM; el-Najjar AR; el-Shahawy EE
Joint Bone Spine; 2012 Mar; 79(2):124-8. PubMed ID: 21981985
[TBL] [Abstract][Full Text] [Related]
12. PADI4 polymorphisms and the functional haplotype are associated with increased rheumatoid arthritis susceptibility: A replication study in a Southern Mexican population.
Baños-Hernández CJ; Navarro-Zarza JE; Parra-Rojas I; Vázquez-Villamar M; Ramón Padilla-Gutiérrez J; Valle Y; Reyes-Castillo Z; Magdalena Torres-Carrillo N; García-Arellano S; Brennan-Bourdon LM; Muñoz-Valle JF
Hum Immunol; 2017 Sep; 78(9):553-558. PubMed ID: 28551357
[TBL] [Abstract][Full Text] [Related]
13. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population.
Gandjbakhch F; Fajardy I; Ferré B; Dubucquoi S; Flipo RM; Roger N; Solau-Gervais E
J Rheumatol; 2009 May; 36(5):881-6. PubMed ID: 19332633
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.
Too CL; Murad S; Dhaliwal JS; Larsson P; Jiang X; Ding B; Alfredsson L; Klareskog L; Padyukov L
Arthritis Res Ther; 2012 Nov; 14(6):R250. PubMed ID: 23164236
[TBL] [Abstract][Full Text] [Related]
15. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
Ceccarelli F; D'Alfonso S; Perricone C; Carlomagno Y; Alessandri C; Croia C; Barizzone N; Montecucco C; Galeazzi M; Sebastiani GD; Minisola G; Fiocco U; Valesini G
Clin Exp Rheumatol; 2012; 30(6):939-42. PubMed ID: 22992305
[TBL] [Abstract][Full Text] [Related]
16. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
[TBL] [Abstract][Full Text] [Related]
17. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
[TBL] [Abstract][Full Text] [Related]
18. Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis.
Cheng J; Zhang H; Zhuang C; Liu R
J Rheumatol; 2012 Jun; 39(6):1159-65. PubMed ID: 22505706
[TBL] [Abstract][Full Text] [Related]
19. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.
Burr ML; Naseem H; Hinks A; Eyre S; Gibbons LJ; Bowes J; Wilson AG; Maxwell J; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Worthington J; ; ; Barton A
Ann Rheum Dis; 2010 Apr; 69(4):666-70. PubMed ID: 19470526
[TBL] [Abstract][Full Text] [Related]
20. The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population.
Chen R; Wei Y; Cai Q; Duan S; Ren D; Shen J; He D; Fang M; Lv K; Cheng N; Sun S
Rheumatol Int; 2011 Dec; 31(12):1631-4. PubMed ID: 20563870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
